Insider Selling: Phreesia, Inc. (NYSE:PHR) Insider Sells $44,790.30 in Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 1,878 shares of the business’s stock in a transaction that occurred on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $44,790.30. Following the completion of the transaction, the insider now directly owns 28,449 shares in the company, valued at approximately $678,508.65. This represents a 6.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Yvonne Hui also recently made the following trade(s):

• On Friday, January 24th, Yvonne Hui sold 127 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total transaction of $3,556.00.
• On Tuesday, January 14th, Yvonne Hui sold 362 shares of Phreesia stock. The stock was sold at an average price of $26.38, for a total transaction of $9,549.56.
• On Friday, January 10th, Yvonne Hui sold 388 shares of Phreesia stock. The shares were sold at an average price of $27.85, for a total transaction of $10,805.80.

Phreesia Trading Up 0.3 %

PHR stock opened at $24.06 on Friday. The firm’s fifty day simple moving average is $26.57 and its two-hundred day simple moving average is $24.26. The stock has a market capitalization of $1.41 billion, a price-to-earnings ratio of -16.37 and a beta of 0.82. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Johnson Financial Group Inc. boosted its holdings in Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after acquiring an additional 896 shares during the period. R Squared Ltd bought a new position in Phreesia during the 4th quarter worth about $30,000. BankPlus Trust Department bought a new position in shares of Phreesia during the fourth quarter valued at approximately $34,000. Quarry LP increased its holdings in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after acquiring an additional 1,923 shares during the period. Finally, Venturi Wealth Management LLC purchased a new position in Phreesia in the fourth quarter valued at about $76,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on PHR shares. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, March 13th. KeyCorp increased their price target on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, January 8th. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, March 13th. Piper Sandler reiterated an “overweight” rating and set a $33.00 target price (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their target price for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia currently has a consensus rating of “Buy” and an average price target of $31.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.